Elevated ALT level and a low AST/ALT ratio suggest nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, increasing the risk of liver cirrhosis and hepatocellular carcinoma [28, 29]. This evidence concerns the gene GPT and hepatocellular carcinoma.